Rapid Therapeutic Science Laboratories, Inc.
company.status.inactiveCIK 1575659fmd_1TD6J2A2RJCE1AGJ05NBQKKSS1Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2014 to Jun 30, 2023, 35 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | – | – | – | – | 0 | 0 | 0 | 0 |
| Gross profit | – | – | – | – | 0 | 0 | 0 | 0 |
| Total operating expenses | 0 | 0 | 0 | – | – | – | – | – |
| Operating income | (0) | (0) | (0) | – | – | – | – | – |
| Interest expense | – | – | 0 | 0 | 0 | 0 | 1 | 2 |
| Other non-operating income (expense) | – | – | 0 | (2) | (0) | (0) | (1) | (1) |
| Income before taxes | – | – | – | – | – | (2) | (3) | (2) |
| Income tax expense | – | – | – | – | – | 0 | 0 | 0 |
| Net income from continuing operations | – | – | – | – | – | (2) | (3) | (2) |
| Net income | (0) | (0) | (0) | (3) | (0) | (2) | (3) | (2) |